ScripThe week before the annual J.P. Morgan Healthcare Conference always brings a flurry of new venture capital financings and the tradition continued in 2025, including Aviceda Therapeutics with a $207.5m
ScripSernova Corp is working to develop a functional cure for type 1 diabetes that could free patients from a lifetime of insulin injections, but despite some early encouraging clinical data and a potenti
ScripIn a deal that Aspect Biosystems Ltd. CEO Tamer Mohamed suggested could mean science fiction coming to real life, the Vancouver, BC-based firm focused on bioprinted tissue therapeutics is teaming wi